Huang, Shang-Chin
Su, Tung-Hung
Tseng, Tai-Chung
Chen, Chi-Ling
Hsu, Shih-Jer
Liao, Sih-Han
Hong, Chun-Ming
Liu, Chen-Hua
Lan, Ting-Yuan
Yang, Hung-Chih
Liu, Chun-Jen
Chen, Pei-Jer
Kao, Jia-Horng http://orcid.org/0000-0002-2442-7952
Funding for this research was provided by:
National Taiwan University Hospital (VN-110-02, 110-S4952, 110-N01, NTUH110-T20)
Ministry of Science and Technology, Taiwan (MOST 109-2326-B-002-012-MY3, MOST 110-2326-B-400-004, MOST 110-2628-B-002-041)
Article History
Received: 24 January 2023
Accepted: 29 April 2023
First Online: 29 May 2023
Declarations
:
: T-HS received a research Grant from Gilead Sciences, and was on speaker’s bureaus for Abbvie, Bayer, Bristol-Myers Squibb, Gilead Sciences, Merck Sharp and Dohme, and Takeda. J-HK has served as a consultant for Abbvie, Abbott, Gilead Sciences, Roche, and Sysmex and on speaker’s bureaus for Abbvie, Bristol-Myers Squibb, Gilead Sciences, Merck Sharp, and Dohme, and Sysmex. S-CH, T-CT, C-LC, S-JH, S-HL, C-MH, C-HL, T-YL, H-CY, C-JL, P-JC declare no conflict of interest.
: This study was approved by the Institutional Review Board of National Taiwan University Hospital (202104086RIND) and conformed to the ethical principles for medical research involving human subjects of the Declaration of Helsinki updated in 2013. The informed consent was waived because this is a retrospective study conducted by a review of medical records only.